Patheon personnel and scientific experts will be available to meet at the CPhI/ICSE – Japan conference in Tokyo from 9-11 April to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals.

Patheon, the pharmaceutical services business owned by DPx Holdings, will feature its wide range of API and complex formulation technologies for small molecules and biologics at the upcoming CPhI/ICSE – Japan conference in Tokyo, Japan.

Tony Pidgeon, senior manager, global science and technology, will present ‘Strategies for Developing Sterile Dosage Forms’ at 4pm on 9 April. Also, Anil Kane PhD., executive director of global head of formulation sciences, will present ‘QbD: A Contract Manufacturers Perspective and Experience, application to the new Process validation guidance strategy’ at 1.45pm.

Patheon personnel will be available to discuss how the company can actively support pharmaceutical and biotech companies in achieving their objectives for both product development and manufacturing.